Effects of Whole Body Vibration on Autonomic Function in Healthy Young and Elderly
- Conditions
- HealthyAging
- Interventions
- Other: Whole Body Vibration
- Registration Number
- NCT03180814
- Lead Sponsor
- Universidade Federal de Pernambuco
- Brief Summary
Aging causes anatomical and physiological changes in the cardiovascular system and autonomic function with decline in its maximum function. This study aimed to evaluate the acute effects of whole body vibration on cardiovascular system, autonomic function and heart variability in healthy young and elderly. The investigators' hypothesis is that whole body vibration has different effects in young and elderly.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 35
- Elderly individuals aged between 60 and 80 years
- Young individuals aged between 18 and 30 years
- Able to walk without assistance
- Good understanding to perform the proposed procedures
- Sedentary or low active
- Body Mass Index (BMI) > 35Kg/m2
- Systolic blood pressure > 140 mmHg or diastolic blood pressure > 90 mmHg (at rest)
- Difficulty adapting to the whole body vibration
- Smoking
- Neuromuscular or degenerative disorders
- Neurological diseases
- Cardiopulmonary comorbidities
- Cardiac arrhythmias
- Osteoarticular disorders
- Use of hormone replacement therapy
- Use medications or supplements known to affect cardiovascular parameters
- Labyrinthitis
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Young Group Whole Body Vibration Healthy young of both sexes between the ages of 18 and 30 years will perform a whole body vibration session Elderly Group Whole Body Vibration Healthy elderly of both sexes between the ages of 60 and 80 years will perform a whole body vibration session
- Primary Outcome Measures
Name Time Method Autonomic Function Change from Baseline Heart rate variability at 5, 10, 15, 20 and 35 minutes Heart rate variability will be assessed from 3-channel holter
- Secondary Outcome Measures
Name Time Method Parasympathetic modulation Change from Baseline Parasympathetic modulation at 5, 10, 15, 20 and 35 minutes Parasympathetic modulation will be assessed from 3-channel holter
Heart Rate Change from Baseline Heart Rate at 5, 10, 15, 20 and 35 minutes Non-invasive measures will be assessed from 3-channel holter
Peripheral oxygen saturation Change from Baseline Peripheral oxygen saturation at 5, 10, 15, 20 and 35 minutes Non-invasive measures will be assessed from pulse oximeter
Blood pressure Change from Baseline Blood pressure at 5, 10, 15, 20 and 35 minutes Non-invasive measures of brachial blood pressure
Sympathovagal Balance Change from Baseline Sympathovagal balance at 5, 10, 15, 20 and 35 minutes Sympathovagal Balance will be assessed from 3-channel holter
Adverse effects Change from Baseline at 20 minutes Adverse effects reported by volunteers
Sympathetic modulation Change from Baseline Sympathetic modulation at 5, 10, 15, 20 and 35 minutes Sympathetic modulation will be assessed from 3-channel holter
Trial Locations
- Locations (1)
Federal University of Pernambuco
🇧🇷Recife, Pernambuco, Brazil